Trade ARTL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Artelo Biosciences, Inc. (ARTL) is trading at US$0.67, up 1.82% today as of Aug 28, 10:21 EDT. The company has a market capitalisation of US$3.18M. Over the past 52 weeks, ARTL has traded between US$0.52 and US$19.91. On Syfe you can trade ARTL with $0 commission and add it to your watchlist.
| Previous close | US$0.66 |
|---|---|
| Market cap | US$3.18M |
| 52-week range | US$0.52 – US$19.91 |
| Volume | 820.53K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Artelo Biosciences, Inc.
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
Year: 2015
Artelo Biosciences Says New Data Shows ART26.12 Reduces Osteoarthritis Pain
Jul 16, 1:38 PM · MT Newswires
Artelo Says ART27.13 Decreases Neuropathic Pain-linked Behaviors in Animals Treated With Paclitaxel
Jul 13, 1:31 PM · MT Newswires
Top Premarket Decliners
May 27, 11:47 AM · MT Newswires
Top Premarket Gainers
May 26, 11:06 AM · MT Newswires
Artelo Biosciences Files Offering for 9.8 Million Common Stock; Shares Tumble
Apr 7, 9:40 PM · MT Newswires
Artelo Biosciences, Inc. (ARTL) stock is trading at US$0.67, +1.82% from the previous close of US$0.66.
The market cap for Artelo Biosciences, Inc. (ARTL) stock is approximately US$3.18M.
The 52-week high for Artelo Biosciences, Inc. (ARTL) stock is US$19.91.
The 52-week low for Artelo Biosciences, Inc. (ARTL) stock is US$0.52.
Artelo Biosciences, Inc. (ARTL) does not currently pay a dividend.
Stay on top of ARTL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
